Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation.
about
Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Atrial natriuretic peptide mod ...... vitro and in vivo evaluation.
@en
Atrial natriuretic peptide mod ...... vitro and in vivo evaluation.
@nl
type
label
Atrial natriuretic peptide mod ...... vitro and in vivo evaluation.
@en
Atrial natriuretic peptide mod ...... vitro and in vivo evaluation.
@nl
prefLabel
Atrial natriuretic peptide mod ...... vitro and in vivo evaluation.
@en
Atrial natriuretic peptide mod ...... vitro and in vivo evaluation.
@nl
P2093
P2860
P356
P1476
Atrial natriuretic peptide mod ...... vitro and in vivo evaluation.
@en
P2093
P2860
P304
P356
10.2147/DDDT.S166749
P407
P577
2018-06-11T00:00:00Z